Streetbeat News

Regulatory

JPM

Jamie Dimon, CEO of JPMorgan Chase, has not endorsed Donald Trump for the 2024 presidential election, casting doubt on rumors that he might be considered for the role of treasury secretary if Trump wins. Dimon's neutral stance conflicts with Trump's preference for loyalists in his cabinet.

Portfolio Pulse from Michael Cohen

October 04, 2024 | 8:14 pm

ULY

A company has been notified by Nasdaq for non-compliance with the minimum bid price requirement, which could lead to delisting if not rectified.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 8:12 pm

AVNW

Aviat Networks has provided its fiscal 2025 revenue guidance, estimating between $450M and $490M, slightly below the $484.16M estimate. The company is addressing material weaknesses in its financial reporting controls and has revised prior financial statements to correct errors.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 8:11 pm

TRVN

Trevena, Inc. has received a delisting notification from Nasdaq due to non-compliance with the minimum stockholder's equity requirement. The company failed to meet the deadline set by the Nasdaq Hearings Panel.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 8:06 pm

CYTO

Altamira Therapeutics Ltd. (NASDAQ:CYTO) received a letter from Nasdaq indicating non-compliance with the minimum bid price rule, as its stock has traded below $1.00 for 30 consecutive days. The company is not eligible for a cure period due to previous reverse stock splits and plans to appeal the decision.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 8:05 pm

COIN

Coinbase Global Inc. shares rose after announcing adjustments to its service offerings to comply with new European regulations. The company plans to delist certain stablecoins for EEA users that don't meet the EU's MiCA standards, with full implementation by December 2024. This proactive regulatory alignment, along with broader market conditions, contributed to the stock's rise.

Portfolio Pulse from Vaishali Prayag

October 04, 2024 | 7:49 pm

ATAI

ENVB

Companies like Mindstate Design Labs and Atai Life Sciences are developing new forms of psychedelics, termed Psychedelics 2.0, to offer mental health benefits with fewer risks. These innovations aim to address the challenges of traditional psychedelics, such as side effects and intensive monitoring requirements. Enveric Biosciences is exploring non-hallucinogenic psychedelics, potentially offering antidepressant-like benefits without extensive clinical sessions.

Portfolio Pulse from Juan Spínelli

October 04, 2024 | 7:39 pm

ONCY

Oncolytics Biotech shares rise as the company announces significant progress in breast and pancreatic cancer treatments and prepares for an accelerated FDA approval process.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 7:19 pm

DAL

Delta Air Lines has received approval from the FAA to use camera-based small drones for visual inspections of aircraft. This development could enhance operational efficiency and safety for Delta.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 6:50 pm

BA

Boeing's union negotiations are set to resume on October 7 with the help of a federal mediator, as reported by Reuters. This development could impact Boeing's labor relations and operational stability.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 6:29 pm